Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Oct;3(5):869–878. doi: 10.1111/j.1365-2125.1976.tb00640.x

Distribution and removal of human serum albumin-technetium 99m instilled intranasally.

F Y Aoki, J C Crowley
PMCID: PMC1428928  PMID: 973982

Abstract

The efficacy of antiviral drugs and vaccines administered intranasally may depend upon the technique of application. The distribution and time-course of removal of human serum albumin-technetium 99m (HSA-Tc 99m)-instilled intranasally were studied in eleven healthy volunteers using a gamma camera and an anterior sodium iodide scintillation detector. In 100 randomized studies material was delivered as drops in the supine position or as a spray to seated subjects. A significantly higher proportion of 'good' distributions (62 in 73 tests) was obtained with drops compared with spray (1 in 27). The volume administered was varied between 0.10 ml and 0.75 ml and the concentration of HSA was changed from 3 to 30% with no significant effect upon the distribution of time-course of removal; pertechnetate in isotonic saline was distributed and removed in a manner comparable to HSA-Tc 99m. Activity recorded by the detector showed an initial rapid fall associated with removal of most of the material from the nasal cavity, followed by a slower decline associated with the removal of material mainly from the anterior region of the nose. A multidose study confirmed that frequent administration by drops is required to maintain a high level of activity in the nasal cavity. Using this technique it should be possible to correlate measurements of antiviral efficacy and vaccines take-rates with certain characteristics of intranasal applicators; such studies may lead to the design of better devices.

Full text

PDF
869

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen I., Lundqvist G. R., Proctor D. F. Human nasal mucosal function in a controlled climate. Arch Environ Health. 1971 Dec;23(6):408–420. doi: 10.1080/00039896.1971.10666029. [DOI] [PubMed] [Google Scholar]
  2. Benjamin P. P. A rapid and efficient method of preparing 99mTc-human serum albumin: its clinical applications. Int J Appl Radiat Isot. 1969 Mar;20(3):187–194. doi: 10.1016/0020-708x(69)90030-1. [DOI] [PubMed] [Google Scholar]
  3. PROCTOR D. F., WAGNER H. N., Jr CLEARANCE OF PARTICLES FROM THE HUMAN NOSE. PRELIMINARY REPORT. Arch Environ Health. 1965 Sep;11:366–371. doi: 10.1080/00039896.1965.10664231. [DOI] [PubMed] [Google Scholar]
  4. Proctor D. F. Airborne disease and the upper respiratory tract. Bacteriol Rev. 1966 Sep;30(3):498–513. doi: 10.1128/br.30.3.498-513.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Quinlan M. F., Salman S. D., Swift D. L., Wagner H. N., Jr, Proctor D. F. Measurement of mucociliary function in man. Am Rev Respir Dis. 1969 Jan;99(1):13–23. doi: 10.1164/arrd.1969.99.1.13. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES